We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+9.58%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.28B
AUM Growth
–
Cap. Flow
+$4.21B
Cap. Flow
% of AUM
98.45%
Top 10 Holdings %
Top 10 Hldgs %
35.15%
Holding
665
New
665
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$172M |
| 2 |
Cardinal Health
CAH
|
+$170M |
| 3 |
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
|
+$152M |
| 4 |
Perrigo
PRGO
|
+$138M |
| 5 |
AGN
Allergan Inc
AGN
|
+$121M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 48.13% |
| 2 | Real Estate | 5.16% |
| 3 | Consumer Discretionary | 4.09% |
| 4 | Industrials | 3.09% |
| 5 | Consumer Staples | 2.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
HCA Healthcare
HCA
$88.4B
| $34.4M | 0.81% |
+955,189
| New | +$36.9M |
|
|
ICPT
27
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $34.4M | 0.8% |
+766,859
| New | +$26.2M |
|
28
Healthcare Realty
HR
$7.56B
| $33.7M | 0.79% |
+1,500,000
| New | +$36.1M |
|
|
RPRX
29
DELISTED
Repros Therapeutics Inc.
RPRX
| $33.7M | 0.79% |
+1,825,000
| New | +$32.2M |
|
30
Medifast
MED
$107M
| $32.2M | 0.75% |
+1,250,000
| New | +$32.8M |
|
31
Universal Health Services
UHS
$10.2B
| $32.1M | 0.75% |
+480,000
| New | +$31.7M |
|
32
Dollar Tree
DLTR
$24.8B
| $30.6M | 0.71% |
+601,698
| New | +$29.3M |
|
|
ELOS
33
DELISTED
Syneron Medical Ltd
ELOS
| $29.1M | 0.68% |
+3,340,000
| New | +$29.9M |
|
|
HTWR
34
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $28.7M | 0.67% |
+301,396
| New | +$27.4M |
|
35
Neurocrine Biosciences
NBIX
$18.2B
| $26.1M | 0.61% |
+1,948,220
| New | +$23.9M |
|
36
McDonald's
MCD
$193B
| $25.5M | 0.6% |
+257,277
| New | +$25.8M |
|
37
NextEra Energy
NEE
$185B
| $25.4M | 0.59% |
+1,246,756
| New | +$24.7M |
|
38
Zimmer Biomet
ZBH
$18.8B
| $25.4M | 0.59% |
+349,011
| New | +$26.1M |
|
39
Liberty Media Series A
FWONA
$23.4B
| $24.6M | 0.57% |
+1,092,369
| New | +$23.2M |
|
|
QCOR
40
DELISTED
QUESTCOR PHARMA INC
QCOR
| $23.4M | 0.55% |
+515,000
| New | +$18.3M |
|
|
VIRX
41
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $21.2M | 0.5% |
+19,396
| New | +$21.6M |
|
42
Duke Energy
DUK
$101B
| $21M | 0.49% |
+311,312
| New | +$22M |
|
43
Baxter International
BAX
$12.8B
| $20.4M | 0.48% |
+543,355
| New | +$20.8M |
|
44
Merck
MRK
$322B
| $20.4M | 0.48% |
+460,030
| New | +$20.5M |
|
|
WMGI
45
DELISTED
Wright Medical Group Inc
WMGI
| $19.1M | 0.45% |
+730,000
| New | +$17.7M |
|
46
Ionis Pharmaceuticals
IONS
$8.93B
| $19M | 0.44% |
+706,804
| New | +$15M |
|
47
Dominion Energy
D
$62.1B
| $18.7M | 0.44% |
+329,548
| New | +$19.3M |
|
48
Regeneron Pharmaceuticals
REGN
$72.9B
| $18.6M | 0.44% |
+82,929
| New | +$19.3M |
|
49
Elevance Health
ELV
$81.5B
| $18.5M | 0.43% |
+225,617
| New | +$16.9M |
|
|
DS
50
DELISTED
Drive Shack Inc.
DS
| $18.3M | 0.43% |
+3,873,624
| New | +$18.5M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Visium Asset Management, which disclosed 665 positions worth $4.28B. Its ten largest holdings account for 35% of the portfolio.
Its largest position is Endo International plc: 4,797,676 shares worth $177M.
By sector, the portfolio is most concentrated in Healthcare at 48% of assets, followed by Real Estate and Consumer Discretionary.
- Visium Asset Management's largest Q2 2013 buy was Endo International plc: 4,797,676 shares worth $177M.
- Visium Asset Management's ten largest holdings make up 35% of its $4.28B portfolio in Q2 2013.
- Visium Asset Management disclosed 665 positions in Q2 2013, its first 13F filing on record.
Based on Visium Asset Management's 13F filing for Q2 2013, filed 14 Aug 2013.